Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy
Background/Aim: Adjuvant chemotherapy for 6 months is the current standard of care after potentially curative resection of pancreatic cancer and yields an overall survival of 15-20 months. Early tumor recurrence before or during adjuvant chemotherapy has not been evaluated so far. These patients may...
Main Authors: | Richard Fischer, Matthias Breidert, Tobias Keck, Frank Makowiec, Christian Lohrmann, Jan Harder |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2012;volume=18;issue=2;spage=118;epage=121;aulast=Fischer |
Similar Items
-
Adrenocortical Carcinoma in an Adult: Eight Months without Recurrence after Resection and Adjuvant Chemotherapy
by: Marcos Duarte Siosaki, et al.
Published: (2014-03-01) -
Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study
by: Charles Poiraud, et al.
Published: (2024-05-01) -
Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2019-03-01) -
Adjuvant Chemo-Radiotherapy versus Chemotherapy in Pancreatic Carcinoma
by: Shimaa Attia, et al.
Published: (2017-06-01) -
Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study
by: Haorui Li, et al.
Published: (2023-10-01)